摘要
目的对阿奇霉素联合孟鲁司特治疗小儿肺炎支原体肺炎的临床疗效进行探讨研究。方法随机抽取2012年8月~2013年8月本院接诊的100例肺炎支原体肺炎患者作为研究对象,将其随机分为观察组和对照组,每组各50例,对照组采取阿奇霉素常规疗法,观察组在对照组的基础上增加孟鲁斯特。观察两组患者的各项临床疗效和有效率。结果观察组总与效率98.0豫显著高于对照组70豫,二者比较差异显著(<0.05),具有统计学意义,观察组各项临床指标均显著优于对照组,二者比较差异显著(<0.05)。结论阿奇霉素联合孟鲁司特治疗小儿肺炎支原体肺炎安全、可靠,临床效果显著。
Objective To study the clinical ef ect of treating mycoplasmal pneumonia in children with azithromycin combined with montelukast.Methods Choosed 100 patients from Aug.2012 to Aug.2013 to divide into study group and control ed group.Patients in controlled group were treated with azithromycin,and the study group were treated with azithromycincombined with montelukast,compared the ef ect of these two groups.Results The total ef ective rate of study group(98.0%)was significantly higher than control ed group(70.0%)(<0.05).The various clinical indexes of study group were significantly bet er than control ed group(<0.05).Conclusion Treating mycoplasmal pneumonia in children with azithromycincombined with montelukast is ef ective to improve the treatment ef ect and worth to extend in clinic.
作者
辛健
XIN Jian(Department of Paediatrics,Maternal and Child Health Hospital of Mianzhu City,Deyang 618200,Sichuan,China)
